Donald G. Payan
2011
In 2011, Donald G. Payan earned a total compensation of $1.2M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,419 |
|---|---|
| Option Awards | $322,082 |
| Salary | $522,365 |
| Other | $5,148 |
| Total | $1,163,014 |
Payan received $522.4K in salary, accounting for 45% of the total pay in 2011.
Payan also received $313.4K in non-equity incentive plan, $322.1K in option awards and $5.1K in other compensation.
Rankings
In 2011, Donald G. Payan's compensation ranked 5,102nd out of 10,747 executives tracked by ExecPay. In other words, Payan earned more than 52.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,102 out of 10,747 | 53rd |
Division Manufacturing | 1,844 out of 3,960 | 53rd |
Major group Chemicals And Allied Products | 390 out of 1,038 | 62nd |
Industry group Drugs | 242 out of 786 | 69th |
Industry Pharmaceutical Preparations | 190 out of 571 | 67th |
Source: SEC filing on April 8, 2014.
Payan's colleagues
We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2011.